Back to Search
Start Over
Management of Knee Osteoarthritis
- Source :
- Rheumatic Disease Clinics of North America. 48:549-567
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
-
Abstract
- Knee osteoarthritis (OA) is a common and morbid condition. No disease-modifying therapies exist; hence the goals of current treatment are to palliate pain and to retain function. OA is significantly influenced by the placebo effect. Nonpharmacologic interventions are essential and have been shown to improve outcomes. Canes, unloading braces, and therapeutic heating/cooling may be valuable. Pharmacotherapy options include topical and oral nonsteroidal anti-inflammatory drugs, duloxetine, and periodic intra-articular glucocorticoids and hyaluronans. Opioids, intra-articular stem cells, and platelet-rich plasma are not recommended. Novel targets such as nerve growth factor are under investigation and may be approved soon for OA pain.
- Subjects :
- medicine.medical_specialty
Nonsteroidal
business.industry
Nonpharmacologic interventions
General Medicine
Osteoarthritis
musculoskeletal system
Placebo
medicine.disease
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Knee pain
Pharmacotherapy
chemistry
Rheumatology
Medicine
Duloxetine
030212 general & internal medicine
medicine.symptom
business
Intensive care medicine
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 0889857X
- Volume :
- 48
- Database :
- OpenAIRE
- Journal :
- Rheumatic Disease Clinics of North America
- Accession number :
- edsair.doi.dedup.....fcc4d88f8be63a19bdcb8dacc13d8967
- Full Text :
- https://doi.org/10.1016/j.rdc.2022.02.011